Contract VA797P16A0006
Vyera Pharmaceuticals, Llc · Department Of Veterans Affairs · October 26, 2015
Vyera Pharmaceuticals, Llc was awarded a federal contract by Department Of Veterans Affairs on October 26, 2015 for an undisclosed amount of work in pharmaceutical preparation manufacturing. This is a task or delivery order issued under parent IDIQ V797D6002E. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 19, 2016. If all options are exercised, the contract could reach $428,000.
Contract details
- PIID
- VA797P16A0006
- Parent IDIQ
- V797D6002E
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- October 26, 2015
- Latest action
- September 19, 2016
Description
BPA CANCELLATION
Modification timeline
-
September 19, 2016Mod P00004$0
-
August 1, 2016Mod P00003DARAPRIM NEW PACKAGE SIZE ADD$0
-
May 4, 2016Mod P00002EXTENDING CURRENT BPA TO 6/15/2016$0
-
December 30, 2015Mod P000012016 PUBLIC LAW UPDATES$0
-
October 26, 2015Base awardBPA FOR DARAPRIM$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract VA797P16A0006?
Contract VA797P16A0006 is a federal contract awarded to Vyera Pharmaceuticals, Llc by Department Of Veterans Affairs on October 26, 2015 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract VA797P16A0006?
Vyera Pharmaceuticals, Llc won contract VA797P16A0006 from Department Of Veterans Affairs.
How much is contract VA797P16A0006 worth?
Contract VA797P16A0006 has obligated $0 to date but carries a potential ceiling of $428,000 if fully funded and all options are exercised.